Abstract

TGF-β1 is generally accepted as the physiological IgA isotype switch factor. Nevertheless, it is unclear as to which cells in mucus-associated lymphoid tissue provide this cytokine to B cells. Regulatory T cells (Tregs) play immune-suppressive roles by secreting inhibitory cytokines such as TGF-β and IL-10. Thus, it is plausible that Tregs are involved in IgA class switch recombination (CSR) in MALT. We explored, in the present study, the possibility that CD4+CD25+ T cells facilitate IgA CSR in murine B cells. In cocultures, CD4+CD25+Foxp3+ T cells stimulated IgA production by splenic B cells to a greater extent than did CD4+CD25−Foxp3− T cells. This effect was markedly abrogated by the addition of anti-TGF-β1 Ab. Additionally, IgA production was paralleled by an increase in germ line transcript α (GLTα), an indicator of IgA CSR. In contrast, CD4+CD25−Foxp3− T cells were more potent at inducing GLTγ1 and GLTɛ production by cocultured splenic B cells than were CD4+CD25+Foxp3+ T cells. Consistent with these results, phenotypic analyses revealed that TGF-β1 and IL-4 were predominantly expressed by CD4+CD25+Foxp3+ T cells and CD4+CD25−Foxp3− T cells, respectively. Furthermore, CD4+CD25+ T cells strongly expressed BAFF, which led to activation-induced deaminase (AID) expression in B cells. Taken together, our results suggest that CD4+CD25+ Tregs have an important effect on IgA isotype commitment by expressing TGF-β1 and BAFF in MALT.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.